Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CALL
Capital One
COF
$133B
| $969K | 0.01% |
7,000
-22,800
| -77% | -$3.2M |
|
1477
Syndax Pharmaceuticals
SNDX
$1.81B
| $968K | 0.01% |
+47,153
| New | +$987K |
|
|
B
1478
PUT
Barrick Mining
B
$79.7B
| $966K | ﹤0.01% |
+57,900
| New | +$983K |
|
|
MLNK
1479
DELISTED
MeridianLink
MLNK
| $961K | ﹤0.01% |
44,995
-48,603
| -52% | -$904K |
|
|
SHYF
1480
DELISTED
The Shyft Group
SHYF
| $960K | ﹤0.01% |
80,923
+16,447
| +26% | +$198K |
|
1481
CALL
Coupang
CPNG
$29.3B
| $957K | ﹤0.01% |
+45,700
| New | +$991K |
|
|
MRO
1482
DELISTED
Marathon Oil Corporation
MRO
| $957K | ﹤0.01% |
33,376
-1,514,676
| -98% | -$42M |
|
1483
PUT
Dover
DOV
$27.2B
| $956K | ﹤0.01% |
+5,300
| New | +$949K |
|
1484
PUT
Builders FirstSource
BLDR
$7.55B
| $955K | ﹤0.01% |
+6,900
| New | +$1.17M |
|
1485
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
| $953K | ﹤0.01% |
3,400
+1,200
| +55% | +$286K |
|
1486
CALL
Constellation Brands
STZ
$23.1B
| $952K | ﹤0.01% |
3,700
-10,700
| -74% | -$2.75M |
|
1487
Prosperity Bancshares
PB
$8.72B
| $952K | ﹤0.01% |
15,564
+6,954
| +81% | +$429K |
|
1488
Genesco
GCO
$378M
| $948K | ﹤0.01% |
36,640
-2,143
| -6% | -$56.1K |
|
1489
SAP
SAP
$251B
| $947K | ﹤0.01% |
+4,693
| New | +$886K |
|
1490
AZZ Inc
AZZ
$4.21B
| $946K | ﹤0.01% |
+12,247
| New | +$957K |
|
1491
Amer Sports
AS
$18.1B
| $943K | ﹤0.01% |
75,008
+34,603
| +86% | +$508K |
|
1492
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.7B
| $942K | ﹤0.01% |
+5,163
| New | +$954K |
|
1493
Vanguard Russell 1000 Value ETF
VONV
$22B
| $941K | ﹤0.01% |
+12,290
| New | +$944K |
|
|
GAP
1494
CALL
The Gap Inc
GAP
$7.27B
| $939K | ﹤0.01% |
+39,300
| New | +$914K |
|
1495
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.74B
| $938K | ﹤0.01% |
+6,447
| New | +$975K |
|
1496
E.W. Scripps
SSP
$305M
| $936K | ﹤0.01% |
298,238
+141,373
| +90% | +$448K |
|
|
WNS
1497
DELISTED
WNS Holdings
WNS
| $934K | ﹤0.01% |
+17,791
| New | +$880K |
|
1498
Genworth Financial
GNW
$3.71B
| $932K | ﹤0.01% |
154,223
+47,461
| +44% | +$295K |
|
1499
Alamo Group
ALG
$1.97B
| $931K | ﹤0.01% |
+5,384
| New | +$1.05M |
|
1500
PUT
Kimberly-Clark
KMB
$36.9B
| $926K | ﹤0.01% |
6,700
+4,900
| +272% | +$654K |
|
Similar funds
Paul Tudor Jones's Q2 2024 Portfolio in Review
As of Q2 2024, Paul Tudor Jones held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Paul Tudor Jones deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Paul Tudor Jones's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Paul Tudor Jones's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Paul Tudor Jones fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Paul Tudor Jones's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Paul Tudor Jones opened 786 new positions and closed 671 in Q2 2024.
- Paul Tudor Jones's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.